Literature DB >> 25855729

The Greater Affinity of JC Polyomavirus Capsid for α2,6-Linked Lactoseries Tetrasaccharide c than for Other Sialylated Glycans Is a Major Determinant of Infectivity.

Luisa J Ströh1, Melissa S Maginnis2, Bärbel S Blaum1, Christian D S Nelson3, Ursula Neu1, Gretchen V Gee3, Bethany A O'Hara3, Nasim Motamedi4, Daniel DiMaio4, Walter J Atwood5, Thilo Stehle6.   

Abstract

UNLABELLED: The human JC polyomavirus (JCPyV) establishes an asymptomatic, persistent infection in the kidneys of the majority of the population and is the causative agent of the fatal demyelinating disease progressive multifocal leukoencephalopathy (PML) in immunosuppressed individuals. The Mad-1 strain of JCPyV, a brain isolate, was shown earlier to require α2,6-linked sialic acid on the lactoseries tetrasaccharide c (LSTc) glycan for attachment to host cells. In contrast, a JCPyV kidney isolate type 3 strain, WT3, has been reported to interact with sialic acid-containing gangliosides, but the role of these glycans in JCPyV infection has remained unclear. To help rationalize these findings and probe the effects of strain-specific differences on receptor binding, we performed a comprehensive analysis of the glycan receptor specificities of these two representative JCPyV strains using high-resolution X-ray crystallography and nuclear magnetic resonance (NMR) spectroscopy, and correlated these data with the results of infectivity assays. We show here that capsid proteins of Mad-1 and WT3 JCPyV can both engage LSTc as well as multiple sialylated gangliosides. However, the binding affinities exhibit subtle differences, with the highest affinity observed for LSTc. Engagement of LSTc is a prerequisite for functional receptor engagement, while the more weakly binding gangliosides are not required for productive infection. Our findings highlight the complexity of virus-carbohydrate interactions and demonstrate that subtle differences in binding affinities, rather than the binding event alone, help determine tissue tropism and viral pathogenesis. IMPORTANCE: Viral infection is initiated by attachment to receptors on host cells, and this event plays an important role in viral disease. We investigated the receptor-binding properties of human JC polyomavirus (JCPyV), a virus that resides in the kidneys of the majority of the population and can cause the fatal demyelinating disease progressive multifocal leukoencephalopathy (PML) in the brains of immunosuppressed individuals. JCPyV has been reported to interact with multiple carbohydrate receptors, and we sought to clarify how the interactions between JCPyV and cellular carbohydrate receptors influenced infection. Here we demonstrate that JCPyV can engage numerous sialylated carbohydrate receptors. However, the virus displays preferential binding to LSTc, and only LSTc mediates a productive infection. Our findings demonstrate that subtle differences in binding affinity, rather than receptor engagement alone, are a key determinant of viral infection.
Copyright © 2015, American Society for Microbiology. All Rights Reserved.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25855729      PMCID: PMC4474300          DOI: 10.1128/JVI.00489-15

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  65 in total

1.  Bound simian virus 40 translocates to caveolin-enriched membrane domains, and its entry is inhibited by drugs that selectively disrupt caveolae.

Authors:  H A Anderson; Y Chen; L C Norkin
Journal:  Mol Biol Cell       Date:  1996-11       Impact factor: 4.138

2.  Case reports of PML in patients treated for psoriasis.

Authors:  Ummehan Ermis; Joachim Weis; Jörg B Schulz
Journal:  N Engl J Med       Date:  2013-09-12       Impact factor: 91.245

3.  PML in a patient treated with fumaric acid.

Authors:  Ummehan Ermis; Joachim Weis; Jörg B Schulz
Journal:  N Engl J Med       Date:  2013-04-25       Impact factor: 91.245

4.  Human glial chimeric mice reveal astrocytic dependence of JC virus infection.

Authors:  Yoichi Kondo; Martha S Windrem; Lisa Zou; Devin Chandler-Militello; Steven J Schanz; Romane M Auvergne; Sarah J Betstadt; Amy R Harrington; Mahlon Johnson; Alexander Kazarov; Leonid Gorelik; Steven A Goldman
Journal:  J Clin Invest       Date:  2014-11-17       Impact factor: 14.808

5.  Electron microscopic observations on a case of progressive multifocal leukoencephalopathy.

Authors:  L Silverman; L J Rubinstein
Journal:  Acta Neuropathol       Date:  1965-11-18       Impact factor: 17.088

6.  Features and development of Coot.

Authors:  P Emsley; B Lohkamp; W G Scott; K Cowtan
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  2010-03-24

7.  Construction of a novel JCV/SV40 hybrid virus (JCSV) reveals a role for the JCV capsid in viral tropism.

Authors:  Benjamin J Chen; Walter J Atwood
Journal:  Virology       Date:  2002-09-01       Impact factor: 3.616

8.  Crystallographic and glycan microarray analysis of human polyomavirus 9 VP1 identifies N-glycolyl neuraminic acid as a receptor candidate.

Authors:  Zaigham Mahmood Khan; Yan Liu; Ursula Neu; Michel Gilbert; Bernhard Ehlers; Ten Feizi; Thilo Stehle
Journal:  J Virol       Date:  2014-03-19       Impact factor: 5.103

9.  Progressive multifocal leukoencephalopathy-associated mutations in the JC polyomavirus capsid disrupt lactoseries tetrasaccharide c binding.

Authors:  Melissa S Maginnis; Luisa J Ströh; Gretchen V Gee; Bethany A O'Hara; Aaron Derdowski; Thilo Stehle; Walter J Atwood
Journal:  MBio       Date:  2013-06-11       Impact factor: 7.867

10.  A structure-guided mutation in the major capsid protein retargets BK polyomavirus.

Authors:  Ursula Neu; Stacy-Ann A Allen; Bärbel S Blaum; Yan Liu; Martin Frank; Angelina S Palma; Luisa J Ströh; Ten Feizi; Thomas Peters; Walter J Atwood; Thilo Stehle
Journal:  PLoS Pathog       Date:  2013-10-10       Impact factor: 6.823

View more
  32 in total

1.  Broadly neutralizing human monoclonal JC polyomavirus VP1-specific antibodies as candidate therapeutics for progressive multifocal leukoencephalopathy.

Authors:  Ivan Jelcic; Benoit Combaluzier; Ilijas Jelcic; Wolfgang Faigle; Luzia Senn; Brenda J Reinhart; Luisa Ströh; Roger M Nitsch; Thilo Stehle; Mireia Sospedra; Jan Grimm; Roland Martin
Journal:  Sci Transl Med       Date:  2015-09-23       Impact factor: 17.956

2.  Multiscale Simulations of Biological Membranes: The Challenge To Understand Biological Phenomena in a Living Substance.

Authors:  Giray Enkavi; Matti Javanainen; Waldemar Kulig; Tomasz Róg; Ilpo Vattulainen
Journal:  Chem Rev       Date:  2019-03-12       Impact factor: 60.622

3.  Susceptibility of Primary Human Choroid Plexus Epithelial Cells and Meningeal Cells to Infection by JC Virus.

Authors:  Bethany A O'Hara; Gretchen V Gee; Walter J Atwood; Sheila A Haley
Journal:  J Virol       Date:  2018-03-28       Impact factor: 5.103

4.  GRK2 mediates β-arrestin interactions with 5-HT2 receptors for JC polyomavirus endocytosis.

Authors:  Colleen L Mayberry; Michael P Wilczek; Tristan M Fong; Sarah L Nichols; Melissa S Maginnis
Journal:  J Virol       Date:  2021-01-13       Impact factor: 5.103

5.  Type I Interferons Regulate the Magnitude and Functionality of Mouse Polyomavirus-Specific CD8 T Cells in a Virus Strain-Dependent Manner.

Authors:  Qingsong Qin; Elizabeth L Frost; Saumya Maru; Aron E Lukacher
Journal:  J Virol       Date:  2016-04-29       Impact factor: 5.103

6.  ERK Is a Critical Regulator of JC Polyomavirus Infection.

Authors:  Jeanne K DuShane; Michael P Wilczek; Colleen L Mayberry; Melissa S Maginnis
Journal:  J Virol       Date:  2018-03-14       Impact factor: 5.103

7.  Infectious Entry and Neutralization of Pathogenic JC Polyomaviruses.

Authors:  Eileen M Geoghegan; Diana V Pastrana; Rachel M Schowalter; Upasana Ray; Wei Gao; Mitchell Ho; Gary T Pauly; Dina M Sigano; Campbell Kaynor; Ellen Cahir-McFarland; Benoit Combaluzier; Jan Grimm; Christopher B Buck
Journal:  Cell Rep       Date:  2017-10-31       Impact factor: 9.423

8.  JC Polyomavirus Entry by Clathrin-Mediated Endocytosis Is Driven by β-Arrestin.

Authors:  Colleen L Mayberry; Ashley N Soucy; Conner R Lajoie; Jeanne K DuShane; Melissa S Maginnis
Journal:  J Virol       Date:  2019-04-03       Impact factor: 5.103

9.  JC Polyomavirus Attachment and Entry: Potential Sites for PML Therapeutics.

Authors:  Colleen L Mayberry; Christian D S Nelson; Melissa S Maginnis
Journal:  Curr Clin Microbiol Rep       Date:  2017-08-01

Review 10.  Sending mixed signals: polyomavirus entry and trafficking.

Authors:  Colleen L Mayberry; Avery Cs Bond; Michael P Wilczek; Kashif Mehmood; Melissa S Maginnis
Journal:  Curr Opin Virol       Date:  2021-03-06       Impact factor: 7.090

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.